{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:57:52Z","timestamp":1785452272083,"version":"3.56.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00317-0","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:02:42Z","timestamp":1785448962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic disorder-MASLD-cardiovascular disease-kidney disease (MMCK) syndrome: an expansion of the Cardiovascular-Kidney-Metabolic (CKM) framework"],"prefix":"10.1186","volume":"12","author":[{"given":"Yan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"317_CR1","doi-asserted-by":"crossref","unstructured":"Ferdinand K C. An overview of cardiovascular-kidney-metabolic syndrome. Am J Manag Care. 2024;30:S181\u20138.","DOI":"10.37765\/ajmc.2024.89670"},{"issue":"20","key":"317_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"E Ndumele C","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148:1606-1635. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"And Behalf The Am Heart Assoc 2023 Cardiovasc-Kidney-Metabolic Health: Presidential Advisory The Am Heart Assoc Circ"},{"key":"317_CR3","doi-asserted-by":"publisher","unstructured":"Manolis A A, Manolis T A, Vouliotis A, Manolis A S. Melatonin and the cardiovascular system. Cardiol Rev. 2026. https:\/\/doi.org\/10.1097\/CRD.0000000000001318.","DOI":"10.1097\/CRD.0000000000001318"},{"issue":"10","key":"317_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.hlc.2025.08.009","volume":"34","author":"H Goodheart R","year":"2025","unstructured":"Goodheart R H, Ayonrinde O T. Connecting the dots: hepatic steatosis as a central player in the choreography of the liver-cardiovascular-kidney-metabolic syndrome. Heart Lung Circ. 2025;34(10):1050\u201359. https:\/\/doi.org\/10.1016\/j.hlc.2025.08.009.","journal-title":"Heart Lung Circ"},{"issue":"6","key":"317_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/MCO.0000000000001070","volume":"27","author":"T Kawahara","year":"2024","unstructured":"Kawahara T. Prediabetes and insulin resistance: effect of vitamin D. Curr Opin Clin Nutr Metabolic Care. 2024;27(6):509\u201314. https:\/\/doi.org\/10.1097\/MCO.0000000000001070.","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"issue":"9","key":"317_CR6","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/s41591-024-03223-z","volume":"30","author":"F Zannad","year":"2024","unstructured":"Zannad F, Sanyal A J, Butler J, Miller V, Harrison S A. Integrating liver endpoints in clinical trials of cardiovascular and kidney disease Nat. Nat Med. 2024;30(9):2423\u201331. https:\/\/doi.org\/10.1038\/s41591-024-03223-z.","journal-title":"Nat Med"},{"issue":"1","key":"317_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s43856-025-01195-w","volume":"5","author":"Q Chen","year":"2025","unstructured":"Chen Q, Zhu Y, Gao J, Ni W, Liu S, Rui F, et al. Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Commun Med. 2025;5(1):492. https:\/\/doi.org\/10.1038\/s43856-025-01195-w.","journal-title":"Commun Med"},{"key":"317_CR8","doi-asserted-by":"publisher","unstructured":"Jankauskas S S, Komici K, Varzideh F, Aversa L S, Kansakar U, D\u2019Onghia M, et al. Cardiovascular\u2013kidney\u2013metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03177-1.","DOI":"10.1186\/s12933-026-03177-1"},{"key":"317_CR9","doi-asserted-by":"publisher","unstructured":"Liu T, Dai Q. Hepatic metabolic burden and all-cause mortality across glucose metabolism statuses in a cardiovascular-kidney-metabolic syndrome population: insights from the National Health and nutrition Examination survey (NHANES). Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03159-3.","DOI":"10.1186\/s12933-026-03159-3"},{"issue":"1","key":"317_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12933-026-03127-x","volume":"25","author":"C Fu","year":"2026","unstructured":"Fu C, Zhang Z, Li Y, Wang F, Li C, Xie Z, et al. Association of the estimated glucose disposal rate combined with a body shape index with all-cause and cardiovascular-specific mortality among individuals with cardiovascular-kidney-metabolic syndrome Cardiovasc. Cardiovasc Diabetol. 2026;25(1):112. https:\/\/doi.org\/10.1186\/s12933-026-03127-x.","journal-title":"Cardiovasc Diabetol"},{"key":"317_CR11","doi-asserted-by":"crossref","unstructured":"Gao Q, Ren W, Du X, Yu Y, Ma Z, Cui Y, et al. Sex-specific associations between depression and cardiovascular-kidney-metabolic syndrome progression: a national cohort study Eur. J. Prev. Cardiol. 2026;zwag135.","DOI":"10.1093\/eurjpc\/zwag135"},{"key":"317_CR12","doi-asserted-by":"publisher","unstructured":"Ioannides A E, Graul E L, Kallis C, Tayal U, M\u00fcllerov\u00e1 H, Quint J K. The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populations. BMC Med. 2026;24(1):24 221. https:\/\/doi.org\/10.1186\/s12916-026-04754-7.","DOI":"10.1186\/s12916-026-04754-7"},{"issue":"2","key":"317_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biom15020213","volume":"15","author":"N Theodorakis","year":"2025","unstructured":"Theodorakis N, Nikolaou M. From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework. Biomolecules. 2025;15(2):15. https:\/\/doi.org\/10.3390\/biom15020213.","journal-title":"Biomolecules"},{"issue":"21","key":"317_CR14","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.3390\/ijms232113320","volume":"23","author":"A Lonardo","year":"2022","unstructured":"Lonardo A, Mantovani A, Targher G, Baffy G. Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. IJMS. 2022;23(21):13320. https:\/\/doi.org\/10.3390\/ijms232113320.","journal-title":"IJMS"},{"key":"317_CR15","doi-asserted-by":"publisher","unstructured":"Arragan Lezama C A, Jaramillo Ramos J J, Armas Eguiz\u00e1bal D, Solares Ovando X S, Minera Villagr\u00e1n J, Males Caiza C J, et al. Cardiovascular-renal-hepatic-metabolic syndrome: interlinked pathophysiology and integrated management approach. Cureus. 2025;17:e85813. https:\/\/doi.org\/10.7759\/cureus.85813.","DOI":"10.7759\/cureus.85813"},{"issue":"11","key":"317_CR16","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.3390\/jcm14113911","volume":"14","author":"D Piatto","year":"2025","unstructured":"Piatto D, De Biasio D, Cesaro F G, Forcina G, Frattolillo V, Colucci A, et al. Liver-kidney crosstalk in major pediatric diseases: unraveling the complexities and clinical challenges. JCM. 2025;14(11):3911. https:\/\/doi.org\/10.3390\/jcm14113911.","journal-title":"JCM"},{"key":"317_CR17","doi-asserted-by":"publisher","unstructured":"Ezeani C, Omaliko C, A YA, Njei B. Mortality, hepatic decompensation, and cardiovascular- and renal-related outcomes in lean versus non-lean patients hospitalized with metabolic dysfunction-associated Steatohepatitis (MASH). Cureus. 2024;16:e60968. https:\/\/doi.org\/10.7759\/cureus.60968.","DOI":"10.7759\/cureus.60968"},{"key":"317_CR18","doi-asserted-by":"publisher","unstructured":"Wang S, Zeng J, Chen Y, Sun F, Ma H, Zhang L, et al. Association between systemic inflammation and worsening renal function in cardiovascular-kidney-metabolic syndrome. Am J Nephrol. 2025;1\u201320. https:\/\/doi.org\/10.1159\/000546130.","DOI":"10.1159\/000546130"},{"issue":"7","key":"317_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/nu16071025","volume":"16","author":"M Lombardi","year":"2024","unstructured":"Lombardi M, Troisi J, Motta B M, Torre P, Masarone M, Persico M. Gut\u2013liver axis dysregulation in portal hypertension: emerging frontiers. Nutrients. 2024;16(7):1025. https:\/\/doi.org\/10.3390\/nu16071025.","journal-title":"Nutrients"},{"key":"317_CR20","doi-asserted-by":"publisher","unstructured":"Khajuria R, Jindal A, Sharma M K, Arora V, Vyas A K, Kumar G, et al. Efficacy and safety of carvedilol in cirrhosis patients with new-onset uncomplicated ascites without high-risk esophageal varices (CARVE-AS trial). Am J Gastroenterol. 2025. https:\/\/doi.org\/10.14309\/ajg.0000000000003650.","DOI":"10.14309\/ajg.0000000000003650"},{"issue":"12","key":"317_CR21","doi-asserted-by":"publisher","first-page":"109748","DOI":"10.1016\/j.celrep.2021.109748","volume":"36","author":"L Catrysse","year":"2021","unstructured":"Catrysse L, Maes B, Mehrotra P, Martens A, Hoste E, Martens L, et al. A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism. Cell Rep. 2021;36(12):109748. https:\/\/doi.org\/10.1016\/j.celrep.2021.109748.","journal-title":"Cell Rep"},{"issue":"7","key":"317_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/life11070672","volume":"11","author":"Y Sun","year":"2021","unstructured":"Sun Y, Rawish E, Nording H M, Langer H F. Inflammation in metabolic and cardiovascular disorders\u2014role of oxidative stress. Life Basel Switz. 2021;11(7):11. https:\/\/doi.org\/10.3390\/life11070672.","journal-title":"Life Basel Switz"},{"key":"317_CR23","doi-asserted-by":"publisher","first-page":"118355","DOI":"10.1016\/j.jep.2024.118355","volume":"332","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Yu M, Xu M, Ji X, Zong X, Zhang Z, et al. Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity. J Ethnopharmacol. 2024;332:118355. https:\/\/doi.org\/10.1016\/j.jep.2024.118355.","journal-title":"J Ethnopharmacol"},{"key":"317_CR24","doi-asserted-by":"publisher","first-page":"747794","DOI":"10.3389\/fimmu.2021.747794","volume":"12","author":"J George","year":"2021","unstructured":"George J, Zhang Y, Sloan J, Sims J M, Imig J D, Zhao X. Tim-1 deficiency aggravates high-fat diet-induced Steatohepatitis in mice Front. Front. Immunol. 2021;12:747794. https:\/\/doi.org\/10.3389\/fimmu.2021.747794.","journal-title":"Front. Immunol"},{"issue":"1","key":"317_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00018-021-04019-x","volume":"79","author":"A Bhusal","year":"2022","unstructured":"Bhusal A, Rahman M H, Suk K. Hypothalamic inflammation in metabolic disorders and aging. Cell Mol Life Sci. CMLS. 2022;79(1):32. https:\/\/doi.org\/10.1007\/s00018-021-04019-x.","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"317_CR26","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.physbeh.2025.114917","volume":"296","author":"R Dali","year":"2025","unstructured":"Dali R, Langlet F. Tanycytes in the nexus of hypothalamic inflammation, appetite control, and obesity. Physiol Behav. 2025;296:114917. https:\/\/doi.org\/10.1016\/j.physbeh.2025.114917.","journal-title":"Physiol Behav"},{"key":"317_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.atherosclerosis.2016.01.037","volume":"246","author":"C Naito","year":"2016","unstructured":"Naito C, Hashimoto M, Watanabe K, Shirai R, Takahashi Y, Kojima M, et al. Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis. 2016;246:344-351. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.037.","journal-title":"Atherosclerosis"},{"issue":"1","key":"317_CR28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-025-56885-9","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang K, Gan J, Wang B, Lei W, Zhen D, Yang J, et al. FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice Nat. Nat Commun. 2025;16(1):1661. https:\/\/doi.org\/10.1038\/s41467-025-56885-9.","journal-title":"Nat Commun"},{"key":"317_CR29","doi-asserted-by":"publisher","first-page":"1706091","DOI":"10.3389\/fendo.2025.1706091","volume":"16","author":"S Weng","year":"2026","unstructured":"Weng S, Ding C, Lin J, Chai D. ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting Front. Front. Endocrinol. 2026;16:1706091. https:\/\/doi.org\/10.3389\/fendo.2025.1706091.","journal-title":"Front. Endocrinol"},{"issue":"11","key":"317_CR30","doi-asserted-by":"publisher","first-page":"100446","DOI":"10.1016\/j.xcrm.2021.100446","volume":"2","author":"H Fukami","year":"2021","unstructured":"Fukami H, Morinaga J, Nakagami H, Hayashi H, Okadome Y, Matsunaga E, et al. Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia Cell Rep. Med. Cell Rep. Med. 2021;2(11):100446. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100446.","journal-title":"Cell Rep. Med"},{"key":"317_CR31","doi-asserted-by":"publisher","first-page":"102326","DOI":"10.1016\/j.tice.2024.102326","volume":"87","author":"Q Wang","year":"2024","unstructured":"Wang Q, Li Y, Yuan H, Peng L, Dai Z, Sun Y, et al. Hypoxia preconditioning of human amniotic mesenchymal stem cells enhances proliferation and migration and promotes their homing via the HGF\/C-MET signaling axis to augment the repair of acute liver failure tissue Cell. Tissue Cell. 2024;87:102326. https:\/\/doi.org\/10.1016\/j.tice.2024.102326.","journal-title":"Tissue Cell"},{"issue":"11","key":"317_CR32","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s40618-025-02634-0","volume":"48","author":"M Yang","year":"2025","unstructured":"Yang M, Gao L, Xu B, Li W, Chen C, Chen J, et al. Role of the E26 transformation specific transcription factor family in metabolic disorders. J Endocrinol Invest. 2025;48(11):2547\u201361. https:\/\/doi.org\/10.1007\/s40618-025-02634-0.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"317_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41418-024-01311-8","volume":"31","author":"J Cai","year":"2024","unstructured":"Cai J, Li C, Liu S, Tan M, Sun Y, Sun X, et al. Angiogenin-mediated tsRnas control inflammation and metabolic disorder by regulating NLRP3 inflammasome. Cell Death Differ. 2024;31(8):1057\u201369. https:\/\/doi.org\/10.1038\/s41418-024-01311-8.","journal-title":"Cell Death Differ"},{"issue":"1","key":"317_CR34","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1038\/s41467-021-26909-1","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ren L, Sun X, Zhang Z, Liu J, Xin Y, et al. Angiogenin mediates paternal inflammation-induced metabolic disorders in offspring through sperm tsRnas. Nat Commun. 2021;12(1):6673. https:\/\/doi.org\/10.1038\/s41467-021-26909-1.","journal-title":"Nat Commun"},{"issue":"9","key":"317_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/met.2021.0022","volume":"19","author":"D Rodr\u00edguez-Vera","year":"2021","unstructured":"Rodr\u00edguez-Vera D, Vergara-Casta\u00f1eda A, Lazcano-Orozco D K, Ram\u00edrez-V\u00e9lez G, Vivar-Sierra A, Araiza-Mac\u00edas M, et al. Inflammation parameters associated with metabolic disorders: relationship between diet and microbiota. Metab Syndr Relat Disord. 2021;19(9):469\u201382. https:\/\/doi.org\/10.1089\/met.2021.0022.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"317_CR36","doi-asserted-by":"publisher","first-page":"2375555","DOI":"10.1080\/21505594.2024.2375555","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yang H, Wu P, Yang S, Xue W, Xu B, et al. Akkermansia muciniphila: a promising probiotic against inflammation and metabolic disorders. Virulence. 2024;15(1):2375555. https:\/\/doi.org\/10.1080\/21505594.2024.2375555.","journal-title":"Virulence"},{"issue":"10","key":"317_CR37","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/1751-7915.14293","volume":"16","author":"W Wu","year":"2023","unstructured":"Wu W, Kaicen W, Bian X, Yang L, Ding S, Li Y, et al. Akkermansia muciniphila alleviates high-fat-diet -related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids Microb. Microb Biotechnol. 2023;16(10):1924\u201339. https:\/\/doi.org\/10.1111\/1751-7915.14293.","journal-title":"Microb Biotechnol"},{"issue":"10","key":"317_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"D Cani P","year":"2022","unstructured":"Cani P D, Depommier C, Derrien M, Everard A, De Vos W M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms Nat. Nat Rev Gastroenterol Hepatol. 2022;19(10):625\u201337. https:\/\/doi.org\/10.1038\/s41575-022-00631-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"317_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells12060901","volume":"12","author":"T-Y Cheng","year":"2023","unstructured":"Cheng T-Y, Chang C-C, Luo C-S, Chen K-Y, Yeh Y-K, Zheng J-Q, et al. Targeting Lung\u2013gut axis for regulating pollution particle\u2013mediated inflammation and metabolic disorders. Cells. 2023;12(6):12. https:\/\/doi.org\/10.3390\/cells12060901.","journal-title":"Cells"},{"issue":"S2","key":"317_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.33594\/000000819","volume":"59","author":"K Lewandowska","year":"2025","unstructured":"Lewandowska K, Miku\u0142a-Pietrasik J, Ksi\u0105\u017cek K, Tykarski A, Uruski P. Allopurinol attenuates senescence and oxidative stress in endothelial cells exposed to Serum from hypertensive patients with hyperuricemia - a Pilot study. Cell Physiol Biochem. 2025;59(S2):125\u201337. https:\/\/doi.org\/10.33594\/000000819.","journal-title":"Cell Physiol Biochem"},{"key":"317_CR41","doi-asserted-by":"publisher","unstructured":"Watanabe T, Ishikawa M, Abe K, Ishikawa T, Imakiire S, Masaki K, et al. Increased Lung uric acid deteriorates pulmonary arterial hypertension. JAHA. 2021;10(23):e022712. https:\/\/doi.org\/10.1161\/JAHA.121.022712.","DOI":"10.1161\/JAHA.121.022712"},{"key":"317_CR42","doi-asserted-by":"crossref","unstructured":"Yang H, Yi X, Song S, Wang M, Tan W, Zhu Y, et al. The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice Acta Biochim. Biophys Sin. 2026.","DOI":"10.3724\/abbs.2025191"},{"key":"317_CR43","doi-asserted-by":"crossref","unstructured":"Russo E, Viazzi F, Pontremoli R, Angeli F, Barbagallo CM, Berardino B, et al. Predictive value of TG\/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. Lipids Health Dis. 2025;24:21.","DOI":"10.1186\/s12944-025-02440-w"},{"issue":"10","key":"317_CR44","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.122.319989","volume":"130","author":"P Patel K","year":"2022","unstructured":"Patel K P, Katsurada K, Zheng H. Cardiorenal syndrome: the role of neural connections between the Heart and the kidneys Circ. Circ Res. 2022;130(10):1601\u201317. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.319989.","journal-title":"Circ Res"},{"issue":"20","key":"317_CR45","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.jacc.2025.08.086","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M, Testani J, Butler J, Zannad F, Lam C S P, Vaduganathan M, et al. Chronic kidney disease in patients with Heart failure with a Preserved Ejection Fraction. JACC. 2025;86(20):1900\u201316. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.086.","journal-title":"JACC"},{"issue":"7","key":"317_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11886-013-0380-4","volume":"15","author":"D Shchekochikhin","year":"2013","unstructured":"Shchekochikhin D, Schrier R W, Lindenfeld J. Cardiorenal syndrome: pathophysiology and treatment Curr. Curr Cardiol Rep. 2013;15(7):380. https:\/\/doi.org\/10.1007\/s11886-013-0380-4.","journal-title":"Curr Cardiol Rep"},{"issue":"12","key":"317_CR47","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2215\/CJN.03150509","volume":"4","author":"M Sarraf","year":"2009","unstructured":"Sarraf M, Masoumi A, Schrier R W. Cardiorenal syndrome in acute decompensated Heart failure Clin. Clin J Am Soc Nephrol. 2009;4(12):2013\u201326. https:\/\/doi.org\/10.2215\/CJN.03150509.","journal-title":"Clin J Am Soc Nephrol"},{"key":"317_CR48","doi-asserted-by":"publisher","unstructured":"Clark C R, Khalil R A. Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1\u20137)\/MasR signaling in normal and hypertensive pregnancy. Biochemical Pharmacol. 2024;220:220 115963. https:\/\/doi.org\/10.1016\/j.bcp.2023.115963.","DOI":"10.1016\/j.bcp.2023.115963"},{"issue":"10","key":"317_CR49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/ars.2012.4641","volume":"19","author":"A Nguyen Dinh Cat","year":"2013","unstructured":"Nguyen Dinh Cat A, Montezano A C, Burger D, Touyz R M. Angiotensin II, NADPH oxidase, and Redox signaling in the vasculature. Antioxid Redox Signal. 2013;19(10):1110\u201320. https:\/\/doi.org\/10.1089\/ars.2012.4641.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"317_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mcna.2016.08.017","volume":"101","author":"C De Mello W","year":"2017","unstructured":"De Mello W C. Local renin angiotensin aldosterone systems and cardiovascular diseases. Med Clin N Am. 2017;101(1):117\u201327. https:\/\/doi.org\/10.1016\/j.mcna.2016.08.017.","journal-title":"Med Clin N Am"},{"issue":"2","key":"317_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-021-01129-6","volume":"23","author":"F Quarti-Trevano","year":"2021","unstructured":"Quarti-Trevano F, Seravalle G, Dell\u2019oro R, Mancia G, Grassi G. Autonomic cardiovascular alterations in chronic kidney disease: effects of dialysis, kidney transplantation, and renal denervation. Curr Hypertens Rep. 2021;23(2):10. https:\/\/doi.org\/10.1007\/s11906-021-01129-6.","journal-title":"Curr Hypertens Rep"},{"key":"317_CR52","doi-asserted-by":"publisher","unstructured":"Pilipovi\u0107 I, Stoji\u0107-Vukani\u0107 Z, Leposavi\u0107 G. Adrenoceptors as potential target for add-on immunomodulatory therapy in multiple sclerosis. Pharmacol Ther. 2023;243:243 108358. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108358.","DOI":"10.1016\/j.pharmthera.2023.108358"},{"key":"317_CR53","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.phrs.2025.107776","volume":"216","author":"J Chen","year":"2025","unstructured":"Chen J, Fei S, Chan L W C, Gan X, Shao B, Jiang H, et al. Inflammatory signaling pathways in pancreatic \u03b2-cell: new insights into type 2 diabetes pathogenesis. Pharmacological Res. 2025;216:107776. https:\/\/doi.org\/10.1016\/j.phrs.2025.107776.","journal-title":"Pharmacological Res"},{"issue":"3","key":"317_CR54","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1681\/ASN.0000000917","volume":"37","author":"H Hu","year":"2026","unstructured":"Hu H, Liang W, Ding G. Podocyte metabolic reprogramming and targeted therapy. JASN. 2026;37(3):619\u201333. https:\/\/doi.org\/10.1681\/ASN.0000000917.","journal-title":"JASN"},{"issue":"7121","key":"317_CR55","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"S Hotamisligil G","year":"2006","unstructured":"Ruan ZB, Zhu L, Yin YG, Chen GC, Cystatin C. Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome. J Res Med Sci Off J Isfahan Univ Med Sci 2014;19:404\u20139. https:\/\/doi.org\/10.1038\/nature05485","journal-title":"Nature"},{"key":"317_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2025.08.003","volume":"86","author":"S Bhardwaj","year":"2025","unstructured":"Bhardwaj S, Gautam R K, Kushwaha S. From senescence to scarring: exploring TGF-\u03b2 signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis. Cytokine Growth Factor Rev. 2025;86:29\u201339. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.08.003.","journal-title":"Cytokine Growth Factor Rev"},{"key":"317_CR57","doi-asserted-by":"publisher","first-page":"114901","DOI":"10.1016\/j.biopha.2023.114901","volume":"164","author":"X Xu","year":"2023","unstructured":"Xu X, Zhang B, Wang Y, Shi S, Lv J, Fu Z, et al. Renal fibrosis in type 2 cardiorenal syndrome: an update on mechanisms and therapeutic opportunities Biomed. Biomed Pharmacother. 2023;164:114901. https:\/\/doi.org\/10.1016\/j.biopha.2023.114901.","journal-title":"Biomed Pharmacother"},{"key":"317_CR58","doi-asserted-by":"publisher","unstructured":"Valero-Mu\u00f1oz M, Oh A, Faudoa E, et al. Endothelial-Mesenchymal Transition in Heart Failure With a Preserved Ejection Fraction: Insights Into the Cardiorenal Syndrome. Circ Heart Fail. 2021;14(9):e008372. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008372","DOI":"10.1161\/CIRCHEARTFAILURE.121.008372"},{"key":"317_CR59","doi-asserted-by":"publisher","unstructured":"Xu K, Wang L, Lv T, Jin C, Wu Q, Zhou Y, et al. Nanomedicines against mitochondrial dysfunction-induced metabolic diseases Adv. Adv Sci. 2025;12(48):e14522. https:\/\/doi.org\/10.1002\/advs.202514522.","DOI":"10.1002\/advs.202514522"},{"issue":"1","key":"317_CR60","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1038\/s41467-022-33776-x","volume":"13","author":"I Cokic","year":"2022","unstructured":"Cokic I, Chan S F, Guan X, Nair A R, Yang H-J, Liu T, et al. Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium Nat. Nat Commun. 2022;13(1):6394. https:\/\/doi.org\/10.1038\/s41467-022-33776-x.","journal-title":"Nat Commun"},{"issue":"10354","key":"317_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","volume":"400","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Docherty K F, Claggett B L, Jhund P S, De Boer R A, Hernandez A F, et al. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials the Lancet. Lancet. 2022;400(10354):757\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(22)01429-5.","journal-title":"Lancet"},{"issue":"9","key":"317_CR62","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1111\/dom.16569","volume":"27","author":"P Fadini G","year":"2025","unstructured":"Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788\u20131801. https:\/\/doi.org\/10.1016\/S0140-6736(22)02074-8","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"317_CR63","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","volume":"103","author":"M Ridker P","year":"2001","unstructured":"Chertow GM, Correa-Rotter R, Vart P, et al. Effects of dapagliflozin in chronic kidney disease, with and without other cardiovascular medications: DAPA-CKD Trial. J Am Heart Assoc. 2023;12(9):e028739. https:\/\/doi.org\/10.1161\/JAHA.122.028739","journal-title":"Circulation"},{"issue":"sup241","key":"317_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00365510802150158","volume":"68","author":"P Devarajan","year":"2008","unstructured":"Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease Scand. Scand J Clin Lab Invest. 2008;68(sup241):89\u201394. https:\/\/doi.org\/10.1080\/00365510802150158.","journal-title":"Scand J Clin Lab Invest"},{"key":"317_CR65","doi-asserted-by":"publisher","first-page":"1030968","DOI":"10.3389\/fcvm.2022.1030968","volume":"9","author":"C Catena","year":"2022","unstructured":"Catena C, Brosolo G, Da Porto A, Donnini D, Bulfone L, Vacca A, et al. Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension. Front. Cardiovasc. Med. 2022;9:1030968. https:\/\/doi.org\/10.3389\/fcvm.2022.1030968.","journal-title":"Front. Cardiovasc. Med"},{"issue":"15","key":"317_CR66","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.3390\/jcm14155303","volume":"14","author":"T Naganuma","year":"2025","unstructured":"Naganuma T, Iwai T, Kabata D, Machida Y, Takemoto Y, Uchida J. Impact of metabolic syndrome on renal and cardiovascular outcomes in renal transplant recipients: a single-center study in Japan. JCM. 2025;14(15):5303. https:\/\/doi.org\/10.3390\/jcm14155303.","journal-title":"JCM"},{"key":"317_CR67","doi-asserted-by":"crossref","unstructured":"S\u00e1gi B, Vas T, Csiky B, Nagy J, Kov\u00e1cs T. Does metabolic syndrome and its components have prognostic significance for renal and cardiovascular outcomes in IgA nephropathy? Biomedicines. 2024;12.","DOI":"10.20944\/preprints202404.0980.v1"},{"issue":"8","key":"317_CR68","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4239\/wjd.v11.i8.322","volume":"11","author":"F Pazos","year":"2020","unstructured":"Pazos F. Range of adiposity and cardiorenal syndrome. WJD. 2020;11(8):322\u201350. https:\/\/doi.org\/10.4239\/wjd.v11.i8.322.","journal-title":"WJD"},{"issue":"1","key":"317_CR69","doi-asserted-by":"publisher","first-page":"2288670","DOI":"10.1155\/crit\/2288670","volume":"2025","author":"C Kwon Y I","year":"2025","unstructured":"Kwon Y I C, Khan A, Bruno D A, Hashmi Z A, Chery J. The use of normothermic machine perfusion for staged combined Heart\u2013liver transplant. Case Rep Transpl. 2025;2025(1):2288670. https:\/\/doi.org\/10.1155\/crit\/2288670.","journal-title":"Case Rep Transpl"},{"issue":"1","key":"317_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/biomedicines13010135","volume":"13","author":"N Theodorakis","year":"2025","unstructured":"Theodorakis N, Nikolaou M. Integrated management of cardiovascular\u2013renal\u2013hepatic\u2013metabolic syndrome: expanding roles of SGLT2is, GLP-1RAs, and GIP\/GLP-1RAs. Biomedicines. 2025;13(1):135. https:\/\/doi.org\/10.3390\/biomedicines13010135.","journal-title":"Biomedicines"},{"issue":"18","key":"317_CR71","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.3390\/jcm14186348","volume":"14","author":"W Matuszewski","year":"2025","unstructured":"Matuszewski W, Tomaszek L, Szklarz M, G\u00f3rny J, Kordas B, Rutkowska J, et al. Beyond the Cardio\u2013renal\u2013metabolic axis: emerging therapeutic targets and Novel mechanisms of Action of Flozins. JCM. 2025;14(18):6348. https:\/\/doi.org\/10.3390\/jcm14186348.","journal-title":"JCM"},{"issue":"20","key":"317_CR72","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","volume":"373","author":"S Hayek S","year":"2015","unstructured":"Hayek S S, Sever S, Ko Y-A, Trachtman H, Awad M, Wadhwani S, et al. Quyyumi a A and Reiser J 2015 Soluble urokinase receptor and chronic kidney disease N. N Engl J Med. 2015;373(20):1916\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1506362.","journal-title":"N Engl J Med"},{"issue":"22","key":"317_CR73","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.jacc.2023.09.811","volume":"82","author":"J Butler","year":"2023","unstructured":"Butler J, Abildstr\u00f8m S, Borlaug B A, Davies M J, Kitzman D W, Petrie M C, et al. Semaglutide in patients with obesity and Heart failure across Mildly reduced or Preserved Ejection Fraction. J Am Coll Cardiol. 2023;82(22):2087\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2023.09.811.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"317_CR74","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan N, Hennige A M, Staiger H, Machann J, Schick F, Kr\u00f6ber, et al. \u03b12-Heremans-Schmid Glycoprotein\/ fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. \u03b12-Heremans-Schmid Glycoprotein\/fetuin-A Is Associated Insulin Resist Fat Accumulation The Liver Humans Diabetes Care. 2006;29(4):853\u201357. https:\/\/doi.org\/10.2337\/diacare.29.04.06.dc05-1938.","journal-title":"\u03b12-Heremans-Schmid Glycoprotein\/fetuin-A Is Associated Insulin Resist Fat Accumulation The Liver Humans Diabetes Care"},{"issue":"10","key":"317_CR75","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jacc.2025.06.058","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M, Zile M R, Kramer C M, M JM, Baum S J, Litwin S E, et al. Influence of type 2 diabetes on the effects of tirzepatide in patients with Heart failure and a Preserved Ejection Fraction with obesity JACC. JACC. 2025;86(10):696\u2013707. https:\/\/doi.org\/10.1016\/j.jacc.2025.06.058.","journal-title":"JACC"},{"issue":"1","key":"317_CR76","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000548494","volume":"15","author":"M\u00e1rquez D","year":"2025","unstructured":"M\u00e1rquez D, Ortiz A, Gonz\u00e1lez-Moreno, Ruilope L M, Ruiz-Hurtado G, M\u00e1rquez DF, et al. Finerenone: evidence for benefit in early stages of cardiovascular-kidney-metabolic syndrome. Cardiorenal Med. 2025;15(1):619\u201325. https:\/\/doi.org\/10.1159\/000548494.","journal-title":"Cardiorenal Med"},{"key":"317_CR77","unstructured":"Bay\u00e9s-Gen\u00eds A, J N, Lup\u00f3n J Soluble ST2 for prognosis and monitoring in heart failure."},{"issue":"5","key":"317_CR78","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00395-007-0662-3","volume":"102","author":"C Wollert K","year":"2007","unstructured":"Wollert K C. Growth-differentiation factor-15 in cardiovascular disease: from bench to bedside, and back Basic Res. Basic Res Cardiol. 2007;102(5):412\u201315. https:\/\/doi.org\/10.1007\/s00395-007-0662-3.","journal-title":"Basic Res Cardiol"},{"issue":"9","key":"317_CR79","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","volume":"33","author":"C Borghi","year":"2015","unstructured":"Borghi C, Rosei E A, Bardin T, Dawson J, Dominiczak A, Kielstein J T, et al. Serum uric acid and the risk of cardiovascular and renal disease J. J Educ Chang Hypertens. 2015;33(9):1729\u201341. https:\/\/doi.org\/10.1097\/HJH.0000000000000701.","journal-title":"J Educ Chang Hypertens"},{"issue":"11","key":"317_CR80","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.cmet.2023.10.008","volume":"35","author":"K Luukkonen P","year":"2023","unstructured":"Luukkonen P K, Porthan K, Ahlholm N, Rosqvist F, Dufour S, Zhang X-M, et al. The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans Cell Metab. Cell Metab. 2023;35(11):1887\u201396.e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.008.","journal-title":"Cell Metab"},{"key":"317_CR81","doi-asserted-by":"publisher","unstructured":"Speliotes E K, Schneider C V. PNPLA3 I148M interacts with environmental triggers to cause human disease. Liver Int. 2025;45(3):45 e16106. https:\/\/doi.org\/10.1111\/liv.16106.","DOI":"10.1111\/liv.16106"},{"issue":"5","key":"317_CR82","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/liv.15533","volume":"43","author":"J Boeckmans","year":"2023","unstructured":"Boeckmans J, Gatzios A, Schattenberg J M, Koek G H, Rodrigues R M, Vanhaecke T. PNPLA3 I148M and response to treatment for hepatic steatosis: a systematic review liver int. Liver Int. 2023;43(5):975\u201388. https:\/\/doi.org\/10.1111\/liv.15533.","journal-title":"Liver Int"},{"issue":"5","key":"317_CR83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5694\/mja2.70008","volume":"223","author":"A Adams L","year":"2025","unstructured":"Adams L A, Kemp W W, Muller K R, Powell E E, Roberts S K, Bertot L C, et al. Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary Med. The Med J Aust. 2025;223(5):268\u201376. https:\/\/doi.org\/10.5694\/mja2.70008.","journal-title":"The Med J Aust"},{"key":"317_CR84","doi-asserted-by":"publisher","first-page":"116020","DOI":"10.1016\/j.bcp.2024.116020","volume":"221","author":"H Mohyeldin R","year":"2024","unstructured":"Mohyeldin R H, Abdelzaher W Y, Sharata E E, Mohamed H M A, Ahmed M Y M, Attia J Z, et al. Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; role of IGF1\/p-AKT\/FOXO1 and NF\u03baB\/IL-1\u03b2\/TNF-\u03b1 signaling pathways in female wistar albino rats. Biochemical Pharmacol. 2024;221:116020. https:\/\/doi.org\/10.1016\/j.bcp.2024.116020.","journal-title":"Biochemical Pharmacol"},{"issue":"1","key":"317_CR85","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hep.32570","volume":"77","author":"P Goyal N","year":"2023","unstructured":"Goyal N P, Rosenthal S B, Nasamran C, Behling C A, Angeles J E, Fishbein M H, et al. Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children. And The NASH Clin Res Network 2023 Nonalcoholic Fat Liver Disease Risk Histologic Severity Are Associated Genetic Polymorphisms Children Hepatol. 2023;77(1):197\u2013212. https:\/\/doi.org\/10.1002\/hep.32570.","journal-title":"And The NASH Clin Res Network 2023 Nonalcoholic Fat Liver Disease Risk Histologic Severity Are Associated Genetic Polymorphisms Children Hepatol"},{"key":"317_CR86","doi-asserted-by":"crossref","unstructured":"Yang H, Yi X, Song S, Wang M, Tan W, Zhu Y, et al. The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice Acta Biochim. Biophys. Sin. 2026.","DOI":"10.3724\/abbs.2025191"},{"key":"317_CR87","doi-asserted-by":"crossref","unstructured":"Russo E, Viazzi F, Pontremoli R, Angeli F, Barbagallo C M, Berardino B, et al. Borghi C, and Working group on uric acid and cardiovascular risk of the Italian Society of hypertension (SIIA) 2025 Predictive value of TG\/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study Lipids Health Dis. 24 21.","DOI":"10.1186\/s12944-025-02440-w"},{"key":"317_CR88","doi-asserted-by":"publisher","unstructured":"Hirose K, Nakanishi K, Daimon M, Sawada N, Yoshida Y, Iwama K, et al. Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight\/obese Japanese subjects in a general community. Cardiovasc Diabetol. 2021;20(1):20 22. https:\/\/doi.org\/10.1186\/s12933-020-01201-6.","DOI":"10.1186\/s12933-020-01201-6"},{"issue":"3, may-jun","key":"317_CR89","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21149\/15414","volume":"66","author":"R Guardado-Mendoza","year":"2024","unstructured":"Guardado-Mendoza R, Vargas-Ortiz K, Reyes-Escogido MDL, R R-C, Evia-Viscarra L. Prediabetes, undiagnosed T2D, insulin resistance and metabolic syndrome in Guanajuato, Mexico. Salud Publica Mex. 2024;66(3, may-jun):288\u201395. https:\/\/doi.org\/10.21149\/15414.","journal-title":"Salud Publica Mex"},{"issue":"2","key":"317_CR90","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam M, Fan J-G, Yu M-L, Wong VW-S, Cua I H, Liu C-J, et al. The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease Hepatol. Hepatol Int. 2025;19(2):261\u2013301. https:\/\/doi.org\/10.1007\/s12072-024-10774-3.","journal-title":"Hepatol Int"},{"issue":"5","key":"317_CR91","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","volume":"169","author":"M Younossi Z","year":"2025","unstructured":"Younossi Z M, Zelber-Sagi S, Lazarus J V, Wong VW-S, Yilmaz Y, Duseja A, et al. Global Consensus recommendations for metabolic dysfunction-associated Steatotic liver disease and Steatohepatitis Gastroenterology. Gastroenterology. 2025;169(5):1017\u201332.e2. https:\/\/doi.org\/10.1053\/j.gastro.2025.02.044.","journal-title":"Gastroenterology"},{"key":"317_CR92","doi-asserted-by":"publisher","unstructured":"Kawaharata W, Tanaka M, Sato T, Akiyama Y, Hosaka I, Aida H, et al. Incorporation of metabolic dysfunction-associated Steatotic liver disease in the Health Stage of cardiovascular-kidney-metabolic syndrome improves Predictive ability for coronary artery disease in a Japanese general population. JAHA. 2025;14(16):14 e043173. https:\/\/doi.org\/10.1161\/JAHA.125.043173.","DOI":"10.1161\/JAHA.125.043173"},{"issue":"5","key":"317_CR93","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour J-F, Petta S, Romero-Gomez M, Allison M, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis am. Am. J. Gastroenterol. 2017;112(5):740\u201351. https:\/\/doi.org\/10.1038\/ajg.2016.453.","journal-title":"Am. J. Gastroenterol"},{"key":"317_CR94","doi-asserted-by":"crossref","unstructured":"Grundy S M, Stone N J, Bailey A L, Beam C, Birtcher K K, Blumenthal R S, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical Practice guidelines Circulation. 2019;139.","DOI":"10.1161\/CIR.0000000000000698"},{"key":"317_CR95","doi-asserted-by":"crossref","unstructured":"Heidenreich P A, Bozkurt B, Aguilar D, Allen L A, Byun J J, Colvin M M, et al. Vest a R and Yancy C W 2022, 2022 AHA\/ACC\/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical Practice guidelines Circulation. 145.","DOI":"10.1161\/CIR.0000000000001073"},{"issue":"22","key":"317_CR96","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIR.0000000000001029","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati M, Levy P D, Mukherjee D, Amsterdam E, Bhatt D L, Birtcher K K, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the evaluation and diagnosis of Chest Pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical Practice guidelines. 2021, 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline The Evaluation Diagnosis Chest Pain: Report The Am Coll Cardiol\/Am Heart Assoc Joint Comm Clin Pract Guidelines Circ. 2021;144(22):144. https:\/\/doi.org\/10.1161\/CIR.0000000000001029.","journal-title":"2021, 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline The Evaluation Diagnosis Chest Pain: Report The Am Coll Cardiol\/Am Heart Assoc Joint Comm Clin Pract Guidelines Circ"},{"issue":"7","key":"317_CR97","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"O Kleindorfer D","year":"2021","unstructured":"Kleindorfer D O, Towfighi A, Chaturvedi S, Cockroft K M, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient Ischemic Attack: a Guideline from the American Heart Association\/American stroke Association. 2021, 2021 Guideline The Prev Stroke Patients Stroke Transient Ischemic Attack: Guideline The Am Heart Assoc\/Am Stroke Assoc Stroke. 2021;52(7):52. https:\/\/doi.org\/10.1161\/STR.0000000000000375.","journal-title":"2021, 2021 Guideline The Prev Stroke Patients Stroke Transient Ischemic Attack: Guideline The Am Heart Assoc\/Am Stroke Assoc Stroke"},{"issue":"34","key":"317_CR98","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"J Visseren F L","year":"2021","unstructured":"Visseren F L J, Mach F, Smulders Y M, Carballo D, Koskinas K C, B\u00e4ck, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice Eur. Eur Heart J. 2021;42(34):3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"issue":"4","key":"317_CR99","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"S Nasreddine Z","year":"2005","unstructured":"Nasreddine Z S, Phillips N A, B\u00e9dirian, Charbonneau S, Whitehead V, Collin I, et al. The montreal Cognitive assessment, MoCA: a brief screening tool for Mild Cognitive impairment. J Am Geriatrics Soc. 2005;53(4):695\u201399. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatrics Soc"},{"key":"317_CR100","doi-asserted-by":"publisher","unstructured":"Stevens P E, Ahmed S B, Carrero J J, Foster B, Francis A, Hall R K, et al. KDIGO 2024 clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"317_CR101","unstructured":"Anon KDIGO_2012_CKD_GL."},{"key":"317_CR102","doi-asserted-by":"publisher","unstructured":"Tonelli M, Berns J S, Bozkurt B, Cheung R S, Cuevas Y, Effa E E, et al. KDIGO 2026 clinical Practice Guideline for the management of anemia in chronic kidney disease (CKD). Kidney Int. 2026;109(1):S1\u201399. https:\/\/doi.org\/10.1016\/j.kint.2025.06.006.","DOI":"10.1016\/j.kint.2025.06.006"},{"key":"317_CR103","doi-asserted-by":"crossref","unstructured":"De Wolski K, Prince D K, Mariuma D, Arora N, Velu T N. Gupta a and Bansal N 2025 experience and outcomes of a dedicated Cardio-nephrology service: a Step towards integrated cardiovascular-kidney-metabolic syndrome care Kidney360.","DOI":"10.34067\/KID.0000001096"},{"issue":"6","key":"317_CR104","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/jcm14062102","volume":"14","author":"C Carollo","year":"2025","unstructured":"Carollo C, Evola S, Sorce A, Cirafici E, Bennici M, Mul\u00e8 G, et al. Mission and one-year experience of a kidney\u2013Heart outpatient service: a patient-centered management model. JCM. 2025;14(6):2102. https:\/\/doi.org\/10.3390\/jcm14062102.","journal-title":"JCM"},{"issue":"3","key":"317_CR105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.repc.2024.09.003","volume":"44","author":"R Cal\u00e7a","year":"2025","unstructured":"Cal\u00e7a R, Malho A, Domingos A T, Menezes Fernandes R, Gomes Da Silva F, Aguiar C, et al. Multidisciplinary cardiorenal program for heart failure patients: improving outcomes through comprehensive care Rev. Rev Port Cardiol. 2025;44(3):179\u201387. https:\/\/doi.org\/10.1016\/j.repc.2024.09.003.","journal-title":"Rev Port Cardiol"},{"issue":"5","key":"317_CR106","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.kint.2024.12.021","volume":"107","author":"D Zhu","year":"2025","unstructured":"Zhu D, Judge P K, Wanner C, Haynes R, Herrington W G. The prevention and management of chronic kidney disease among patients with metabolic syndrome. Kidney Int. 2025;107(5):816\u201324. https:\/\/doi.org\/10.1016\/j.kint.2024.12.021.","journal-title":"Kidney Int"},{"key":"317_CR107","doi-asserted-by":"publisher","unstructured":"Arun A J, Darji B, Baig M, Frishman W H, Aronow W S. Survodutide: A Dual GLP-1\/Glucagon Agonist Reshaping Cardiometabolic Care. Cardiol Rev. 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000001062.","DOI":"10.1097\/CRD.0000000000001062"},{"issue":"1","key":"317_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcrm2010001","volume":"2","author":"C Carollo","year":"2026","unstructured":"Carollo C, Sorce A, Evola S, Caruso G F, Cirafici E, Tartamella M G, et al. Transitional care in cardiorenal patients: a proposal for an integrated model. JCRM. 2026, 2 1;2(1):1. https:\/\/doi.org\/10.3390\/jcrm2010001.","journal-title":"JCRM"},{"issue":"1","key":"317_CR109","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11897-025-00711-2","volume":"22","author":"S Sarnaik K","year":"2025","unstructured":"Sarnaik K S, Mirzai S. When the Heart, kidneys, and body waste away: a review of cachexia in cardiorenal syndrome. Curr Heart Fail Rep. 2025;22(1):23. https:\/\/doi.org\/10.1007\/s11897-025-00711-2.","journal-title":"Curr Heart Fail Rep"},{"issue":"2","key":"317_CR110","doi-asserted-by":"publisher","first-page":"151519","DOI":"10.1016\/j.semnephrol.2024.151519","volume":"44","author":"D Mohottige","year":"2024","unstructured":"Mohottige D. Paving a path to equity in cardiorenal care. Semin Nephrol. 2024;44(2):151519. https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151519.","journal-title":"Semin Nephrol"},{"key":"317_CR111","doi-asserted-by":"publisher","first-page":"888240","DOI":"10.3389\/fcvm.2022.888240","volume":"9","author":"C-Y Hsieh","year":"2022","unstructured":"Hsieh C-Y, Kao H-M, Sung K-L, Sposato L A, Sung S, Lin S-J. Validation of risk scores for predicting atrial fibrillation detected after stroke based on an electronic Medical record algorithm: a registry-claims-electronic Medical record linked data study Front. Front. Cardiovasc. Med. 2022;9:888240. https:\/\/doi.org\/10.3389\/fcvm.2022.888240.","journal-title":"Front. Cardiovasc. Med"},{"issue":"11","key":"317_CR112","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/ejhf.70053","volume":"27","author":"Y Huber","year":"2025","unstructured":"Huber Y, Hofmann L, Prochaska J H, Koeck T, Chalabi J, Pfeiffer N, et al. Incidence of major cardiovascular events in patients with metabolic dysfunction-associated Steatotic liver disease in the general population Eur. Eur J Heart Fail. 2025;27(11):2490\u2013500. https:\/\/doi.org\/10.1002\/ejhf.70053.","journal-title":"Eur J Heart Fail"},{"key":"317_CR113","doi-asserted-by":"crossref","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality atherosclerosis. 2024;397 118585.","DOI":"10.1016\/j.atherosclerosis.2024.118585"},{"issue":"18","key":"317_CR114","doi-asserted-by":"publisher","first-page":"9788","DOI":"10.3390\/ijms25189788","volume":"25","author":"Y-L Tain","year":"2024","unstructured":"Tain Y-L, Hsu C-N. Maternal dietary strategies for improving offspring cardiovascular\u2013kidney\u2013metabolic Health: a scoping review. IJMS. 2024;25(18):9788. https:\/\/doi.org\/10.3390\/ijms25189788.","journal-title":"IJMS"},{"key":"317_CR115","doi-asserted-by":"publisher","unstructured":"Tain Y-L, Hsu C-N. Maternal polyphenols and offspring cardiovascular\u2013kidney\u2013metabolic Health. Nutrients. 2024;16(18):16 3168. https:\/\/doi.org\/10.3390\/nu16183168.","DOI":"10.3390\/nu16183168"},{"key":"317_CR116","doi-asserted-by":"publisher","first-page":"111926","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Virginia Manzi M, Trama U, Lembo M, et al. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: a propensity score-matched study diabetes Res. Clin. Diabetes Res Clin Pr. 2024;218:111926. https:\/\/doi.org\/10.1016\/j.diabres.2024.111926.","journal-title":"Diabetes Res Clin Pr"},{"key":"317_CR117","doi-asserted-by":"publisher","unstructured":"Ruiz-Garc\u00eda A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Mart\u00ednez, Pallar\u00e9s-Carratal\u00e1 V, Arranz-Mart\u00ednez E. Prevalence rates of abdominal obesity, high waist-to-height ratio and excess adiposity, and their associated Cardio-kidney-metabolic factors: SIMETAP-AO study Nutrients. Nutrients. 2024;16(22):16 3948. https:\/\/doi.org\/10.3390\/nu16223948.","DOI":"10.3390\/nu16223948"},{"key":"317_CR118","doi-asserted-by":"publisher","unstructured":"Carvalho L, Tyd\u00e9n M, Shimari M, Zhuge Z, Schiffer T, De Oliveira Monteiro M, et al. Protective effects of the food supplement Flexovital in a model of cardiovascular-kidney-metabolic syndrome in mice Nutrients. Nutrients. 2024;16(23):16 4105. https:\/\/doi.org\/10.3390\/nu16234105.","DOI":"10.3390\/nu16234105"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00317-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:02:44Z","timestamp":1785448964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00317-0","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}